Literature DB >> 9593874

Evidence for the interaction of glutamate and NK1 receptors in the periphery.

S M Carlton1, S Zhou, R E Coggeshall.   

Abstract

It is known that Substance P (SP) enhances glutamate- and N-methyl-D-aspartate (NMDA)-induced activity in spinal cord dorsal horn neurons and that this enhancement is important in the generation of wind-up and central sensitization. It is now known that SP and glutamate receptors are present on sensory axons in rat glabrous skin. This raises the issue as to whether SP and glutamate interact in the periphery. Using the tail skin in rats, the present study demonstrates 1) that unmyelinated axons at the dermal-epidermal junction immunostain for antibodies directed against NMDA, non-NMDA or SP (NK1) receptors; 2) that glutamate injected into the tail skin results in dose-dependent nociceptive behaviors interpreted as mechanical hyperalgesia, mechanical allodynia and thermal hyperalgesia, which are blocked following co-injection with glutamate antagonists; 3) that peripheral injection of SP potentiates glutamate-induced nociceptive behaviors in that the co-injection of SP+glutamate results in a significantly longer duration of behavioral responses compared to the responses seen following injection of either substance alone. These data provide support for the hypothesis that primary afferent neurons might well be subject to similar mechanisms that result in wind-up or central sensitization of spinal cord neurons. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593874     DOI: 10.1016/s0006-8993(97)01471-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  23 in total

Review 1.  Muscle pain due to injury.

Authors:  A H Wheeler; G W Aaron
Journal:  Curr Pain Headache Rep       Date:  2001-10

Review 2.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

3.  Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.

Authors:  Emily O Dumas; Gary M Pollack
Journal:  AAPS J       Date:  2008-11-07       Impact factor: 4.009

4.  Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males.

Authors:  Brian E Cairns; Peter Svensson; Kelun Wang; Eduardo Castrillon; Steen Hupfeld; Barry J Sessle; Lars Arendt-Nielsen
Journal:  Exp Brain Res       Date:  2005-11-16       Impact factor: 1.972

5.  Mechanical allodynia in human glabrous skin mediated by low-threshold cutaneous mechanoreceptors with unmyelinated fibres.

Authors:  Saad S Nagi; David A Mahns
Journal:  Exp Brain Res       Date:  2013-08-18       Impact factor: 1.972

6.  Peripheral Innervation in Children With Global Developmental Delay: Biomarker for Risk for Self-Injurious Behavior?

Authors:  Frank J Symons; Raymond C Tervo; Chantel C Barney; John Damerow; Mona Selim; Brian McAdams; Shawn Foster; Gwen Wendelschafer Crabb; William Kennedy
Journal:  J Child Neurol       Date:  2015-04-26       Impact factor: 1.987

7.  Gargling with ketamine attenuates the postoperative sore throat.

Authors:  A Rudra; Suchanda Ray; S Chatterjee; A Ahmed; S Ghosh
Journal:  Indian J Anaesth       Date:  2009-02

Review 8.  Translational pain research: achievements and challenges.

Authors:  Jianren Mao
Journal:  J Pain       Date:  2009-07-22       Impact factor: 5.820

Review 9.  Myofascial pain disorders: theory to therapy.

Authors:  Anthony H Wheeler
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Central sensitization in fibromyalgia and other musculoskeletal disorders.

Authors:  Lars Arendt-Nielsen; Thomas Graven-Nielsen
Journal:  Curr Pain Headache Rep       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.